Clinical Trials · NCT07224438
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Stephanie B. Seminara, MD
- Enrollment
- 20
- Start date
- Dec 2025
- Locations
- 1 site, United States
- Primary endpoint
- Change of luteinizing hormone (LH) pulse amplitude